Search - tctmd.com

Displaying 21 - 40 of 60

Sort: Relevancy | Date

Presentation NY Valves 2024

Current Treatment Options for HFrEF Patients Failing GDMT

Presenter: Akshay Desai

June 05, 2024

Presentation NY Valves 2024

Secondary MR and GDMT Titration Before M-TEER in the Real-world

Presenter: Donna Mancini

June 05, 2024

Presentation NY Valves 2024

Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients

Presenter: Parag Goyal

June 05, 2024

Presentation THT Abstracts 2024

Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF)

Presenter: Alexandra Steverson

March 05, 2024

Presentation THT Abstracts 2024

High Frequency Virtual Cardiology Intervention (HF-VCI) in implementing Heart Failure Guideline-Directed Medical Therapy (HF-GDMT)

Presenter: Daniel Bensimhon

March 05, 2024

Presentation THT 2024

Leveraging Remote Patient Monitoring to Implement GDMT

Presenter: Marat Fudim

March 05, 2024

Presentation THT 2024

CCM®- Don’t Wait

Presenter: Rami Kahwash

March 05, 2024

Presentation THT 2024

Update on the Integra-D Trial

Presenter: Niraj Varma

March 05, 2024

Presentation THT 2024

Challenges and Opportunities with Contemporary GDMT

Presenter: James Thomas Heywood

March 05, 2024

Presentation THT 2024

Cardiac Recovery in Response to GDMT

Presenter: Andreas Kalogeropoulos

March 04, 2024

Presentation THT 2024

A Challenging TAVR Case: Severe AS and Severe LV Dysfunction (Role of GDMT and MCS)

Presenter: Shmuel Chen

March 04, 2024

Presentation TCT 2023

Revascularization For Patients With Left Ventricular Dysfunction: Are The Trials Still Relevant After a Decade of GDMT and Device Therapy?

Presenter: Clyde Yancy

October 24, 2023

Presentation TCT 2023

Will Advances in GDMT Reduce Need for Mitral TEER in Secondary MR?

Presenter: JoAnn Lindenfeld

October 24, 2023

Presentation TVT 2023

Severity Assessment of TR: Impact of GDMT on Imaging Findings and Invasive Hemodynamics

Presenter: Ulrich Jorde

June 08, 2023

Presentation TVT 2023

Correcting MR Severity is the #1 Priority! - GDMT Optimization Will Always Follow

Presenter: Amar Krishnaswamy

June 08, 2023

Presentation TVT 2023

GDMT First! – M-TEER is Indicated Only After GDMT is Optimized

Presenter: Colin Barker

June 08, 2023

Presentation TVT 2023

"Modern Era" GDMT for Patient With Secondary MR (What Every Structuralist Must Know)

Presenter: Michael Brener

June 07, 2023

Presentation THT 2023

Revivent TC® Patient Screening and Monitoring GDMT Response

Presenter: Michael Pfeiffer

March 21, 2023

Presentation THT 2023

GDMT and Limitations of Available Therapies

Presenter: JoAnn Lindenfeld

March 21, 2023

Presentation THT 2023

Optimizing Euvolemia as Part of GDMT

Presenter: Brad Williams

March 20, 2023

Advertisement

Current Treatment Options for HFrEF Patients Failing GDMT

Secondary MR and GDMT Titration Before M-TEER in the Real-world

Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients

Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF)

High Frequency Virtual Cardiology Intervention (HF-VCI) in implementing Heart Failure Guideline-Directed Medical Therapy (HF-GDMT)

Leveraging Remote Patient Monitoring to Implement GDMT

CCM®- Don’t Wait

Update on the Integra-D Trial

Challenges and Opportunities with Contemporary GDMT

Cardiac Recovery in Response to GDMT

A Challenging TAVR Case: Severe AS and Severe LV Dysfunction (Role of GDMT and MCS)

Revascularization For Patients With Left Ventricular Dysfunction: Are The Trials Still Relevant After a Decade of GDMT and Device Therapy?

Will Advances in GDMT Reduce Need for Mitral TEER in Secondary MR?

Severity Assessment of TR: Impact of GDMT on Imaging Findings and Invasive Hemodynamics

Correcting MR Severity is the #1 Priority! - GDMT Optimization Will Always Follow

GDMT First! – M-TEER is Indicated Only After GDMT is Optimized

"Modern Era" GDMT for Patient With Secondary MR (What Every Structuralist Must Know)

Revivent TC® Patient Screening and Monitoring GDMT Response

GDMT and Limitations of Available Therapies

Optimizing Euvolemia as Part of GDMT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content